Status:
COMPLETED
Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Collaborating Sponsors:
Institute of Technology Transfer & Innovation (ITTI)
Conditions:
Dengue Fever
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Its a double-blind placebo controlled multicenter study involving confirmed dengue patients who are hospitalized.168 Patients will be enrolled according to specific inclusion \& exclusion criteria and...
Detailed Description
Dengue, an important viral diseases of human, has become a life-threatening condition in recent decades. It is found in tropical and subtropical regions worldwide, mostly in urban area. Dengue, a Flav...
Eligibility Criteria
Inclusion
- Patients who are confirmed dengue fever by positive NS1 dengue Antigen and/ Dengue IgM antibody.
- Day of illness ≤ 5 days
Exclusion
- Children (\<18 years)
- Patients already getting Papaya
- Currently pregnant or lactating
- Patients on steroids or any immunosuppressant
- Patients who received platelet transfusion during the same admission
- Patient with known causes of thrombocytopenia
- Patients with alanine aminotransferase (ALT) levels \>150 U/L
- Patient with serum creatinine \>1.4 mg/dl
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT06945679
Start Date
June 1 2024
End Date
February 28 2025
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof Shohael Mahmud Arafat
Dhaka, Dhaka Division, Bangladesh, 1000